Ricerca

Pubblicazioni IRIS

• Quaternary Phosphonium Salts Outperformed Vemurafenib (PLX) and Etoposide Against BRAFV600D,V600E PLX-Resistant Melanoma and MDR Neuroblastoma, Exhibiting No/Low Toxicity on 3T3/HaCaT Cells
  Anno: 2026
• TPP-Based Nanovesicles Kill MDR Neuroblastoma Cells and Induce Moderate ROS Increase, While Exerting Low Toxicity Towards Primary Cell Cultures: An In Vitro Study
  Anno: 2025
• Fighting Melanoma Drug Resistance: Synergistic Effects of Metformin and PLX4032 in Patient-Derived Cells
  Anno: 2025
• Anti-breast cancer activity of biosynthesized selenium nanoparticles using Bacillus coagulans supernatant
  Anno: 2024